Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody ...

Sanofi and its blockbuster drug Dupixent has by the thinnest of margins returned to the top spot for TV drug ad spending in October, beating out fierce rival AbbVie and its immunology drug Rinvoq, ...

According to lawyers at Ropes & Gray, Novo Nordisk misled doctors and consumers about availability of Sanofi's insulin drugs, Lantus and Toujeo. Sanofi-Aventis and its lawyers at Ropes & Gray are ...

Sanofi Consumer Healthcare is pushing back on a recommendation that it discontinue the “#1 doctor-recommended” claim for its Zantac 360° heartburn medicine in a case brought by competitor Johnson & ...

Through a pair of recent clinical milestones, Kymera Therapeutics continues to cash in on its up-to-$2 billion collaboration with Sanofi to develop first-in-class targeted protein degradation (TPD) ...

Regeneron Pharmaceuticals and Sanofi have announced promising outcomes from the open-label Phase IV DISCOVER trial of Dupixent(dupilumab) in treating moderate-to-severe atopic dermatitis (AD) in ...

Good-Loop -- which enables advertisers to measure the carbon emissions generated by their digital ad campaigns -- has inked a partnership with Integral Ad Science, which allows the company to ...

The privately held alcohol marketer is the first company to reveal Big Game ad plans. Sanofi Consumer Healthcare North America has named The Martin Agency as its creative agency of record for its 10 ...

MANILA, Philippines (AP) — The Philippine Food and Drugs Administration has ordered pharmaceutical giant Sanofi Pasteur Inc. to stop airing television and radio advertisements of its dengue vaccine in ...

Sanofi SAN-0.51%decrease; red down pointing triangle plans to buy assets from biopharmaceutical company Inhibrx INBX 1.10%increase; green up pointing triangle in a deal worth up to $2.2 billion as it ...